P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB)
Authors:
- 29 June 2018
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 23 (7-8) , 408-419
Abstract
The over-expressions of brain-derived neurotrophic factor (BDNF) and its tyrosine kinase receptor TrkB have been reported to induce chemo-resistance in neuroblastoma (NB) cells. In this study, we investigated the roles of P53 and BCL2 family members in the protection of BDNF/TrkB from etoposide-induced NB cell death. TB3 and TB8, two tetracycline (TET)-regulated TrkB-expressing NB cell lines, were utilized. The expressions of P53 and BCL2 family members were detected by Western blot or RT-PCR. Transfection of siRNAs was used to knockdown P53 or PUMA. Activated lentiviral was used to over-express PUMA. Cell survival was performed by MTS assay, and the percentage of cell confluence was measured by IncuCyte ZOOM. Our results showed that etoposide treatment induced significant and time-dependent increase of P53, which could be blocked by pre-treatment with BDNF, and knockdown P53 by transfecting siRNA attenuated etoposide-induced TrkB-expressing NB cell death. PUMA was the most significantly changed BCL2 family member after treatment with etoposide, and pre-treatment with BDNF blocked the increased expression of PUMA. Transfection with siRNA inhibited etoposide-induced increased expression of PUMA, and attenuated etoposide-induced NB cell death. We also found that over-expression of PUMA by infection of activated lentiviral induced TrkB-expressing NB cell death in the absence of etoposide, and treatment of BDNF protected NB cells from PUMA-induced cell death. Our results suggested that P53 and PUMA may be potential targets that mediated the protection of BDNF/TrkB from etoposide-induced NB cell death.Keywords
Funding Information
- National Natural Science Foundation of China (81472359, 81272538)
- Natural Science Foundation of Liaoning Province (201602855)
- 2013 Liaoning Climbing Scholar Foundation
This publication has 33 references indexed in Scilit:
- Anti-apoptosis and cell survival: A reviewBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosisOncogene, 2010
- OnTrk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer BiologyClinical Cancer Research, 2009
- Tumour suppression by p53: the importance of apoptosis and cellular senescenceThe Journal of Pathology, 2009
- Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathwayExpert Opinion on Therapeutic Targets, 2007
- Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell deathCell Death & Differentiation, 2006
- The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapyBlood, 2006
- Cell DeathCell, 2004
- Alterations in the apoptotic machinery and their potential role in anticancer drug resistanceOncogene, 2003
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003